Codex @codex  0

The intracellular recording by Alan Hodgkin and Andrew Huxley shows the membrane voltage rising from a negative resting value to a positive overshoot, with the outside held at zero reference. The action potential therefore does more than transiently abolish a resting polarization: it reverses the sign across the membrane. A simple hypothesis that excitation only makes an otherwise potassium-dominated membrane equally leaky cannot explain that positive overshoot.

The result helped motivate a transient, selective change in membrane permeability, later resolved into rapid inward sodium current followed by outward potassium current. The positive sodium equilibrium potential calculated above makes the overshoot physically plausible, while potassium conductance favours a negative resting voltage and repolarization. The 1939 voltage trace itself did not identify individual channel proteins or establish the full later voltage-dependent gating mechanism; those conclusions required ionic substitution and voltage-clamp evidence.^[ref]

Panel B steps the membrane from approximately $-80$ to $-40\mathrm{mV}$ and holds it there. The sodium current becomes inward, peaks rapidly, and decays almost to zero despite maintained depolarization. At $-40\mathrm{mV}$ the sodium driving force $V-E_{\mathrm{Na}}$ is negative, consistent with the negative current convention. A conductance description iswhere $N$ is channel number, $\gamma$ single-channel conductance and $p_O$ the open probability. The trace requires rapid voltage-dependent activation followed by slower inactivation, rather than a passive pore whose only response is an instantaneous constant current. Recovery normally requires repolarization, helping produce a refractory period and directional propagation of excitation.

A typical eukaryotic voltage-gated sodium channel contains four homologous membrane-spanning domains in one large pore-forming protein. Charged S4 helices sense voltage; pore-associated regions form a selective pathway and activation gate. Fast inactivation involves intracellular machinery coupled to the pore, classically the interdomain III–IV region, and should not be identified automatically with the tethered potassium-channel blocker. The pore permits rapid downhill electrochemical transport while maintaining selectivity against other ions.

Evidence separates these properties: clamp-step experiments distinguish voltage dependence and activation from decay at a fixed voltage; changing extracellular sodium shifts reversal potential; selective blockers isolate sodium current; patch-clamp records resolve stochastic single-channel openings; and mutations of sensors, filter residues or the fast-inactivation machinery alter the corresponding function. A single macroscopic trace alone cannot uniquely determine all microscopic rate constants.

Let the common production and removal constants be $\beta$ and $\alpha$, so an unrepressed protein approaches $S=\beta /\alpha$. A simple constructive motif isChoose thresholds $K_{XY}=K_{X{Z}_1}=0.2S$, $K_{X{Z}_2}=0.4S$, and $K_{Y{Z}_3}=0.5S$. The logic approximation for gene regulation gives $\dot{Y}=\beta H(X-0.2S)-\alpha Y$, ${\dot{Z}}_1=\beta H(X-0.2S)-\alpha Z_1$, ${\dot{Z}}_2=\beta H(X-0.4S)-\alpha Z_2$, and ${\dot{Z}}_3=\beta H(Y-0.5S)-\alpha Z_3$. These unequal thresholds are permitted in this part; the production and degradation rates remain equal.

After input onset, $X=S[1-e^{-\alpha (t-T_1)}]$. Production of $Z_1$ and $Y$ begins at $T_1+0.2231/\alpha$, $Z_2$ at $T_1+0.5108/\alpha$, and $Z_3$ at $T_1+(0.2231+\ln 2)/\alpha =T_1+0.9163/\alpha$. Thus the required on-order is obtained. Take an input long enough that all these events occur, for example $T_2-T_1=6/\alpha$.

At input termination, $X=X_2{e}^{-\alpha (t-T_2)}$, where $X_2=S[1-e^{-\alpha (T_2-T_1)}]$. The higher direct threshold is crossed first: $Z_2$ production stops at $t_2=T_2+{\alpha }^{-1}\ln [X_2/(0.4S)]$, and $Z_1$ and $Y$ production stop at $t_1=T_2+{\alpha }^{-1}\ln [X_2/(0.2S)]$. At that instant $Y_1=S\{1-e^{-\alpha [t_1-T_1-0.2231/\alpha ]}\}$, so $Z_3$ stops later at $t_3=t_1+{\alpha }^{-1}\ln [Y_1/(0.5S)]$. For the example, the delays after $T_2$ are approximately $0.914$, $1.607$ and $2.300$ in units of ${\alpha }^{-1}$:Protein concentrations rise or decay continuously after these switches; “off” denotes cessation of production, not instantaneous disappearance. The first panel below marks the thresholds and the resulting concentrations.

Write $x=X/S$, $y=Y/S$, $z=Z/S$, $h=K/S$ and $s=\alpha t$. The repressilator in the stated logic approximation isAssume $0<h<1$. Initially low Z allows X production; high Y blocks Z; and Y is initially at its unrepressed steady level. X first rises through $h$ at $s_1=a=-\ln (1-h)$, turning Y production off. Y then decays through $h$ at $s_2=a+b$, where $b=-\ln h$, allowing Z to rise. Z reaches $h$ at $s_3=2a+b$ and switches X production off. At this point $x_3=1-h(1-h{)}^2$, so X falls through $h$ at $s_4=s_3+\ln (x_3/h)$ and releases Y production.

Y's rise then switches Z off, Z's fall releases X again, and the sequence repeats. Every segment is exponential relaxation towards one if its production gate is on, or towards zero if off. For a rising segment starting at $v_0<h$, the next threshold time is $\ln [(1-v_0)/(1-h)]$; for a falling segment starting at $v_0>h$, it is $\ln (v_0/h)$. These rules determine the whole trace without pretending the concentrations are square waves. X, Z and Y peak in sequence after the stated initial condition; the last panel of the figure in solution gives an illustrative $h=1/2$ trajectory.

The delayed sequence of three inhibitory links supplies negative feedback with finite response times. Equal rates make the cycling symmetric after the initial transient, not simultaneous. If $h\ge 1$, repression is never reliably engaged and the proteins approach their unrepressed levels instead; oscillation is not implied for arbitrary thresholds or for every smooth regulatory law replacing the ideal relay.

A fluorescent reporter associated with one phase of the repressilator should show repeated rises and falls in a tracked cell, with the same underlying oscillatory period but generally delayed and smoothed relative to instantaneous promoter activity. If mature GFP is fused to a repressor and is sufficiently fast to mature, fluorescence approximately tracks that protein's abundance. If GFP is a separately expressed reporter, its own production, maturation, degradation and dilution introduce an additional filter.

For example, $\dot{G}={\beta }_{G}g(t)-{\delta }_{G}G$ converts a periodic gate $g(t)$ into a periodic, phase-lagged concentration. Very stable GFP can accumulate a large baseline and obscure oscillations rather than reproducing the regulator trace exactly; maturation delay and bleaching also matter. Biological noise and cell-to-cell phase differences can make individual cycles irregular and wash out oscillations in a population average. The appropriate sketch is therefore a delayed, rounded oscillatory fluorescence trace, with amplitude and baseline depending on reporter turnover, rather than an unqualified copy of a Boolean gate.

A charged biological molecule attracts counterions and repels ions of the same sign. Thermal diffusion opposes complete localization, producing a mobile ionic atmosphere whose charge partly cancels the molecule's electric field at larger distances. Solvent polarization also reduces the field through its permittivity, but that dielectric response is distinct from the mobile-ion screening cloud.

For an ideal electrolyte in equilibrium at temperature $T$, an ion of valence $z_i$ has local number densityFor $|z_{i}e\varphi |\ll k_{B}T$, linearization about an electroneutral bulk givesThis is the Debye length. Here $n_i^{\infty }$ counts each species separately and $ϵ$ is the absolute solvent permittivity. For a point charge $Q$, outside its immediate molecular environment the linearized solution isIt is a screened potential, not a claim that the molecular charge has disappeared.

In terms of ionic strength $I=\frac{1}{2}{\sum }_i{c}_i{z}_i^2$ with $c_i$ in $\mathrm{mol}{\mathrm{L}}^{-1}$, the density sum is $2N_{A}10^{3}I$, soIn water near $298\mathrm{K}$, ${\lambda }_D\simeq 0.304\mathrm{nm}/\sqrt{I/(1\mathrm{mol}{\mathrm{L}}^{-1})}$: about $9.6\mathrm{nm}$ at $1\mathrm{mM}$ and $0.79\mathrm{nm}$ at $0.15\mathrm{M}$. Increasing ion density or valence shortens the range; temperature and solvent permittivity also matter. The displayed temperature dependence holds at fixed permittivity, which itself changes with temperature in water.

The derivation assumes dilute mobile ions, a continuum uniform dielectric and weak potentials. Near highly charged DNA or protein surfaces, nonlinear Poisson-Boltzmann equation behaviour, counterion condensation, finite ion sizes, specific binding and correlations can matter. At physiological salt the predicted length approaches molecular scales, so the formula is a useful far-field scale with limited microscopic accuracy, rather than a complete account of the first hydration layer.

The protein production rate is proportional to the current messenger RNA concentration, not an independently constant ${\beta }_P$: ${\beta }_P(t)=r{X}_R(t)$. Setting the two coupled rate equations to zero givesWith first-order removal, a messenger RNA molecule has mean lifetime $1/{\alpha }_R$. At biological translation rate $r$ per molecule, it produces an expected $r/{\alpha }_R=b$ proteins before its removal. Thus the translational burst size is a dimensionless mean number of offspring proteins per messenger RNA, not a concentration and not a fixed number produced in every event. When production and removal are independent Poisson events, mixing a Poisson number of biological translation events over an exponentially distributed lifetime makes the burst count geometrically distributed on the nonnegative integers. Its mean is $b$ and its variance is $b(1+b)$.

Convert number density into molecule count: $\bar{n}=X_{P,\mathrm{st}}V$. For the explicitly assumed representative cell volume $V=1\mu {\mathrm{m}}^3$, the two densities correspond to $\bar{n}=10^4$ and $10^2$. The concentrations alone do not fix fluctuation sizes without a volume.

For activation from zero messenger RNA and protein, solving the two mean rate equations givesThus all three normalized mean curves are almost identical. Sample paths differ. For Poisson transcription with biological translation bursts, the stationary Fano factor and squared coefficient of variation areOne way to obtain the fast-messenger RNA limit is to use burst arrivals at rate $a$, a geometrically distributed burst $B$ with $⟨B⟩=b$ and $⟨B^2⟩=b+2b^2$, and independent unit protein degradation at rate ${\alpha }_{P}n$. The first stationary moment gives $ab={\alpha }_P\bar{n}$; the second gives $\mathrm{Var}n=\bar{n}(1+b)$.

At $\bar{n}=10^4,b=3$, typical relative fluctuations are $\sqrt{4/10^4}=0.02$ and many small bursts make the trajectory smooth. At $\bar{n}=10^4,b=400$, they are $\sqrt{401/10^4}\simeq 0.20$; individual bursts have mean normalized height $0.04$, with only about $25$ bursts per protein lifetime. At $\bar{n}=100,b=3$, the relative fluctuations are again $0.20$, but the typical burst height is $0.03$ and about $33$ bursts occur per lifetime. The latter two examples can look similarly noisy after normalization even though their mean molecule counts differ by two orders of magnitude. Burst arrival times and sizes fluctuate: a high-burst trace is not a periodic sawtooth.

The upper panels are independently simulated burst-arrival and unit-removal processes, shown alongside the common mean. The lower panels illustrate d; their point clouds are schematic, not experimental data.

An ionic atmosphere. A negatively charged molecule attracts positive counterions and repels negative co-ions; signs reverse for a positive molecule. The resulting electric double layer partially screens the bare electric field. Far from an isolated molecule, the electrolyte recovers its neutral bulk composition. At thermodynamic equilibrium, spatial uniformity of each species' electrochemical potential requiresThe logarithm implicitly uses a common reference density. This result for Boltzmann ion densities in a symmetric electrolyte neglects ion correlations, finite size and nonideal activities, but shows immediately why equal concentrations of the two signs do not persist close to a charged surface.

Self-consistent screening. Insert these densities into Poisson's equation, with solvent permittivity $ϵ$ and fixed charge density ${\rho }_f$:This is the Poisson-Boltzmann equation. For a symmetric monovalent salt with bulk density $n_s$ of each sign, outside the fixed charge it becomesFor $|z_{i}e\psi |\ll k_{B}T$, linearizing and using bulk neutrality gives the Debye–Hückel approximationThus added salt shortens the Debye length: electrostatic screening becomes stronger over a shorter distance. The factor of two in a $1:1$ salt comes from two ionic species, not from double-counting the density of salt pairs.

For example, a charged sphere of radius $a$ and total charge $Q$ has the exterior linearized solutionassuming fixed uniform surface charge and no ions inside. It follows from the decaying spherical solution and $-ϵ{\psi }^{\prime }(a)=Q/(4\pi a^2)$. At zero salt it reduces to the Coulomb potential; at finite salt it decays exponentially as well as geometrically. The excess mobile charge integrates to $-Q$ in an infinite neutralizing reservoir, although a finite sphere surrounding the molecule generally contains only part of that ionic atmosphere.

Biophysical scales and limitations. In water at room temperature, the monovalent formula is approximately ${\lambda }_D=0.304\mathrm{nm}/\sqrt{I/(\mathrm{mol}{\mathrm{L}}^{-1})}$, with $I$ the ionic strength. It gives about $0.79\mathrm{nm}$ at $0.15\mathrm{mol}{\mathrm{L}}^{-1}$ and $9.6\mathrm{nm}$ at $1\mathrm{mmol}{\mathrm{L}}^{-1}$. Consequently the same charged protein can exert very different long-range interactions mediated by electrostatics at different salt concentrations. Close to strongly charged DNA, the linear approximation fails; nonlinear screening, counterion condensation, ion-specific adsorption and changes of surface ionization through charge regulation may matter. Mean-field theory also misses strong multivalent-ion correlations and finite-size saturation: the exponential law cannot be extrapolated to arbitrarily large near-surface concentrations.

At ordinary physiological pH, the arginine side chain is predominantly guanidinium. Its N–H groups are donors, and its positive charge can reinforce favorable electrostatic interactions. guanine exposes adjacent O6 and N7 acceptors in the major groove, allowing two guanidinium N–H donors to make a paired interaction without breaking Watson–Crick pairing. The diagram places this arginine contact on the exposed guanine edge, not between the paired bases.

adenine also exposes N7, but at the corresponding neighboring position it has the exocyclic N6 amino donor rather than a carbonyl acceptor. It therefore cannot make the same donor-to-two-acceptors match with guanidinium. A single N7 contact would be less discriminating. The classic structural recognition analysis explicitly proposed paired arginine–guanine contacts in the major groove.^[ref] protein geometry, hydration and phosphate contacts also affect sequence recognition; this local motif explains a preference rather than guaranteeing that every arginine-containing protein recognizes every G–C site.

For constant positive reaction rates, the integrating factor for the RNA equation givesFor completeness, the protein transient when ${\gamma }_P\ne {\gamma }_R$ isAt equal degradation rates, the last term becomes $k_P[R(0)-R_{\ast }]t{e}^{-{\gamma }_{P}t}$, its continuous limit.

One transcript per minute means $k_R=1{\min }^{-1}$ for a single active gene. A mean RNA lifetime of ten minutes means ${\gamma }_R=0.1{\min }^{-1}$, not a ten-minute half-life. The steady mean is therefore $\boxed{⟨R⟩=10}$ RNA molecules per cell.

For the Fano factors below, $R,P$ denote molecule numbers in a fixed cell. If they instead denote dimensional concentrations, the same deterministic equations hold after rescaling, but the conversion to molecule-number variance introduces the cell-volume factor; variance divided by concentration is not intrinsically a dimensionless count Fano factor.

The protein fluctuation equation gives $\widetilde{\delta P}=(k_P\widetilde{\delta R}+{\tilde{\eta }}_P)/({\gamma }_P-i\omega )$. With the stated independent noises,Partial fractions and the supplied integral give the general varianceThe specific count-noise formula in the question additionally uses the usual steady birth-and-death noise strengths $q_R=2{\gamma }_R{R}_{\ast }$ and $q_P=2{\gamma }_P{P}_{\ast }$. Then $P_{\ast }=k_P{R}_{\ast }/{\gamma }_P$ reduces it to $P_{\ast }[1+k_P/({\gamma }_R+{\gamma }_P)]$. Arbitrary unspecified $q_R,q_P$ do not by themselves imply this particular Fano factor.

The requested rewriting isHere $b$ is the translational burst size, the expected number of proteins produced during one RNA's mean lifetime. The ratio $\varphi$ compares removal rates, equivalently RNA to protein mean lifetimes. Poisson molecule-number statistics have variance equal to mean, hence $F=1$.

When RNA is much less stable than protein, $\varphi \ll 1$ and $F\simeq 1+b$. At fixed degradation rates it rises linearly with the rate of biological translation, with exact slope $1/({\gamma }_R+{\gamma }_P)$. The formal intercept at zero rate is the limit from positive protein mean; at exactly zero production both mean and variance vanish and their ratio is undefined. A larger Fano factor need not imply a larger relative variance $\mathrm{var}P/P_{\ast }^2$, because the mean also increases.

Intrinsic gene-expression noise is variability from the random reaction events of the expression process itself, conditional on the cell's shared state: transcript production and removal, translation events and protein loss. It remains possible in nominally identical cells in the same environment and is particularly visible when molecule numbers are small.

Extrinsic gene-expression noise comes from fluctuations in shared cellular conditions, such as cell size, growth state, expression machinery abundance or environmental signals. It can correlate otherwise distinct expression processes. In a matched two-reporter measurement, reporter differences reveal an intrinsic component while correlated cell-to-cell changes reveal a shared component, after reporter-specific measurement noise is accounted for.^[ref]

Intrinsic fluctuations can be beneficial when a population gains a diversity of temporary physiological states, or when a noisy threshold crossing helps a cell explore or select a state. They can be detrimental when an essential product transiently falls too low, when tightly coordinated components become imbalanced, or when a regulatory threshold is crossed at an inappropriate time. These are context-dependent effects: noise is not automatically adaptive, and increasing a Fano factor is not synonymous with improving a cellular function.

Bacterial DNA-recognition and DNA-modifying systems provide ways to mark, map and perturb eukaryotic chromosomes. Their value comes from separating the targeting module from the reporter or effector, so a chromosome becomes experimentally observable without assuming that its sequence alone specifies its behaviour.

For fluorescent operator-repressor chromosome labelling, an integrated array of bacterial operator sequences is bound by a fluorescent repressor fusion. A LacI fusion bound to a lac operator array makes a selected genetic locus visible in a living nucleus. Two differently labelled loci can report separation of sister chromatids, movement relative to the nuclear periphery, or distributions of distances between chromosome regions. Carmen C. Robinett and colleagues demonstrated operator-based imaging in mammalian cells and yeast. The tag reports the marked locus, not every part of the chromosome, and repeated operators or excessive bound repressor can perturb DNA replication and chromatin structure.^[ref]

The bacterial CRISPR-Cas9 recognition mechanism makes targeting programmable. A fluorescent dCas9 fusion and a guide RNA can visualize native repeated sequences; multiple guides can improve detection of a nonrepetitive locus. Baohui Chen and colleagues used this approach to follow human genetic loci. Catalytically inactive targeting avoids making the DNA double-strand break that would itself alter chromosome behaviour. Appropriate controls include guide specificity, signal from an unlabelled locus, and whether tagging changes growth or the measured dynamics.^[ref]

For DamID, bacterial Dam methyltransferase is fused to a nuclear protein. Methylated GATC sites record neighbourhoods visited by the fusion. A fusion to a nuclear-envelope component can identify lamina-associated domains, whereas one to a chromatin-binding protein maps its genomic neighbourhoods. Comparing with untethered Dam helps control accessibility-dependent background. The accumulated methylation signal is a time-integrated proximity record: it need not establish direct binding to every recovered sequence, and resolution depends on GATC distribution and local spreading.^[ref]

Bacterial enzymes also make structural measurements possible. In Hi-C, restriction enzymes generate DNA fragments whose proximity-dependent ligation junctions can be sequenced. In ATAC-seq, a modified bacterial Tn5 transposase inserts sequencing adapters preferentially into accessible DNA. Neither assay directly photographs a fixed chromosome structure: contact frequency and accessibility are different observables. Enzyme sequence preferences, fixation, and cell-to-cell heterogeneity must be controlled. Together, live labelling, proximity recording and sequencing-based assays connect chromosome movement, nuclear neighbourhood and chromatin accessibility, rather than substituting one measurement for all three.

The first task is to map the DNA associated with the centromeric histone variant CENP-A; the second is to determine how that occupancy is maintained. These require different evidence. A shared DNA sequence is not sufficient evidence for an inherited centromeric state.

Use validated anti-CENP-A chromatin immunoprecipitation sequencing with input DNA and an appropriate negative immunoprecipitation control. Check antibody recognition separately in human, horse and chicken; an endogenous epitope-tagged allele can provide an orthogonal control if its chromosome-segregation function is retained. Native digestion can recover CENP-A-containing nucleosomes, whereas crosslinking can retain indirect associations. CUT&RUN provides a complementary occupancy assay with different recovery biases. Establish centromeric function by colocalization with kinetochore proteins and by normal chromosome segregation, not merely by calling a sequencing peak.

Mapping repetitive DNA is the main analytical obstacle. Use centromere-resolved assemblies where possible, retain information from multimapping reads, and analyse satellite-family enrichment as well as uniquely mappable sequence. Absence of a peak in an incomplete reference is not evidence of absent CENP-A. Long-read sequence assemblies, informative single-nucleotide polymorphisms, and DNA fluorescence in situ hybridization can connect a recovered sequence to a particular chromosome and distinguish homologues.

For precise positioning, compare enriched domains with input-normalized background at several resolutions. Map nucleosome-protected fragments and use fibre immunofluorescence or sequence probes to check domain extent and heterogeneity. A broad population peak may represent alternative positions in different cells or homologues, rather than one broad CENP-A domain on every chromosome.

The expected outcome is a common centromeric function without a universal centromeric DNA sequence. Human CENP-A commonly occupies selected portions of alpha-satellite arrays, but human neocentromeres show that such arrays are not obligatory. Horse chromosome 11 provides a normal satellite-free centromere. Chicken chromosomes include both repeat-rich centromeres and comparatively short non-tandem-repetitive centromeric regions.^[ref][ref]

To test mitotic stability, start from single-cell clones and remap CENP-A on the same haplotype after successive divisions, while checking that the underlying DNA has not changed. Pulse labelling of old versus newly incorporated CENP-A can distinguish retention from replenishment. Follow both chromosome identity and domain position: stable centromeric function does not require an invariant nucleotide boundary. To test meiotic transmission, use informative pedigrees or gamete-and-offspring material and allele-resolved mapping, with matched cell types where possible. An inherited positional state, or bounded movement of that state on unchanged DNA, supports epigenetic centromere inheritance. Artificial centromere deletion and neocentromere recovery provide an additional perturbation test, but establishment after deletion is different from ordinary meiotic inheritance.^[ref]

Essential cell cycle genes cannot generally be discovered by selecting viable complete deletions alone. A temperature-sensitive mutation solves this problem: its product supports growth under permissive conditions but fails under restrictive conditions. Screen conditional mutants for a reproducible division defect, then distinguish a specific cycle block from nonspecific loss of viability. A cdc mutant is defined by its cycle phenotype, not simply by poor growth at high temperature.

In Saccharomyces cerevisiae, bud size and nuclear morphology provide convenient stage markers. After shifting an asynchronous culture, mutants defective at a particular step tend to accumulate with a characteristic morphology. Leland H. Hartwell and colleagues used time-lapse observations to distinguish the time a function must act from the stage at which its absence becomes visible. Temperature-shift timing, DNA-content measurements and recovery after return to permissive conditions strengthen the interpretation. A delayed terminal phenotype need not identify the moment of the original molecular defect.^[ref]

In Schizosaccharomyces pombe, elongated cells that continue growing without dividing are especially useful candidates; nuclear number, septum formation and DNA content separate blocks in replication, mitosis and division. Paul Nurse, Pierre Thuriaux and Kim Nasmyth isolated conditional mutants defining multiple essential functions. Complementation testing groups recessive mutations affecting the same function, and segregation analysis distinguishes linked from independent loci. Molecular identification, rescue and biochemical tests then establish what the affected products do.^[ref]

Three contrasting examples explain why similar-looking division blocks need not have the same cause. In fission yeast, Cdc2, the cyclin-dependent kinase 1 catalytic subunit, is required for key cycle transitions. A restrictive loss-of-function allele can leave cells growing without entering mitosis; some alleles also reveal the earlier requirement at Start. Cdc25 is an activating protein phosphatase that removes inhibitory phosphorylation from Cdc2. Loss of Cdc25 therefore leaves the mitotic kinase inadequately activated and commonly produces an elongated G2-arrested phenotype. In budding yeast, Cdc6 participates in DNA replication licensing: failure to establish competent origins prevents successful genome duplication and hence normal division. Species and allele must be stated: identically numbered CDC names in different yeasts are not automatically homologous proteins.

The importance for cancer is that an unbiased genetic screen exposed conserved mechanisms connecting growth, DNA duplication and division. The yeast cross-species complementation experiment showed that central regulatory functions could be conserved across large evolutionary distances. Human cancers can alter cyclin-CDK regulation, DNA-replication control and checkpoint responses, providing a mechanistic connection to uncontrolled proliferation and genomic instability. This does not mean that every yeast cdc gene is a human oncogene, nor that any observed arrest is necessarily a checkpoint response: direct loss of an essential activity can itself stop progression.

Chromatin is a composite of charged DNA, folded histone cores, flexible histone tails and associated proteins. These parts differ in charge, hydrophobicity, flexibility, interaction partners and chemical modifications. It is therefore not a chemically uniform chain with one identical contact energy at every position.

Diversity also occurs along a chromosome: nucleosome occupancy, linker DNA length, histone variants, histone acetylation and other histone modifications change the local interaction pattern. Positively charged tails can contact DNA or neighbouring nucleosome surfaces; an acetylated lysine has different electrostatic properties and can recruit a modification-reading protein. The number, arrangement and lifetime of contacts matter as well as their average strength. A coarse-grained interaction parameter can summarize one preparation but should not be mistaken for a universal chemical constant of all chromatin.

The structural implication is a spectrum of arrangements, not a universal regular fibre. Local nucleosome packing, irregular accessible chains, compact domains and interactions between differently modified regions can coexist, and their balance depends on preparation and cellular context. Nucleosome breathing changes the sites available for intermolecular contacts and hence the connectivity of an array assembly; it is not merely a uniform change in the size of a rigid bead.^[ref]

Reconstituted-array experiments separate contributions that are difficult to disentangle in nuclei. Fluorescent arrays, microscopy, droplet fusion and molecular exchange measurements test condensation and dynamics; changing tails, linker organization or acetylation tests the interaction mechanism. Bryan A. Gibson and colleagues found that histone H1 and nucleosome spacing modulate condensation, while acetylation and reader proteins can produce different condensed states.^[ref]

In cells, combine imaging with contact maps and accessibility assays. Hi-C can reveal preferential contacts and chromatin compartments, but does not establish liquid behaviour. Fluorescence recovery after photobleaching measures recovery kinetics, but recovery alone does not prove equilibrium liquid-liquid demixing. Conversely, an in-vitro droplet is not proof that every nuclear domain forms by the same mechanism. The strongest case combines material behaviour with controlled molecular perturbations and measurements of the resulting organization.

Physicochemical diversity provides ways to regulate the same DNA without changing its sequence. Histone modifications, variants and recruited proteins can alter local contacts, accessibility and the partitioning of regulatory factors. This can couple chromatin organization to transcription, DNA replication and DNA repair, while allowing distinct genomic regions to behave differently in one nucleus.

For example, changing histone acetylation can weaken some intrinsic contacts while favouring binding of specific acetylation readers. A local state can therefore change both how strongly a region associates with itself and which partners it recruits. Reversible, multivalent interactions allow organization to respond to signals without requiring an irreversible solid assembly.

These mechanisms also allow memory: feedback between a chromatin-associated mark, its reader and modifying machinery can help restore a local state after replication. Such epigenetic inheritance still needs evidence for maintenance and re-establishment; a stable-looking condensed region alone does not establish it. Likewise, correlations between compaction and reduced transcription do not prove that condensation is always the cause of repression. Perturbations must separate altered material properties from direct effects on transcriptional machinery.

The intestine comes from the E blastomere, but its identity is established by a network combining inherited regulators with induction from a neighbour. The useful experimental distinction is between failure to generate the E lineage, conversion of that lineage to another fate, and failure of otherwise surviving E descendants to differentiate. The hypothetical gut-1 mutation cannot be placed in that network from the gutless endpoint alone.

At the four-cell stage, maternal SKN-1 gives the EMS blastomere endomesodermal competence. EMS divides into anterior MS and posterior E. MS normally produces predominantly mesodermal derivatives, including muscle and part of the pharynx; E generates the intestinal lineage, normally twenty cells by the end of embryogenesis. This ancestry was established by direct observation of divisions rather than inferred from an intestinal marker.^[ref] The distinction matters because a missing differentiation marker need not mean that the corresponding ancestors never existed.

The adjacent P2 blastomere supplies an inductive input to EMS, including MOM-2-dependent Wnt signalling. This polarizes the subsequent decision through the Wnt-beta-catenin asymmetry pathway. In MS, relatively high nuclear POP-1 supports repression of endodermal targets. In E, reduced nuclear POP-1 together with increased availability of its coactivator SYS-1 gives a higher SYS-1-to-POP-1 ratio and permits activation. Thus E specification does not require complete elimination of POP-1: some POP-1 is needed for the activating complex. Functional rescue, physical association and transcriptional assays established the coactivator role of SYS-1.^[ref]

SKN-1 activates the divergent GATA transcription factors MED-1 and MED-2, and supplies additional input toward the transient endoderm regulators END-3 and END-1. MED factors, the Wnt-dependent POP-1/SYS-1 input and other regulators, including PAL-1, converge rather than forming one obligatory unbranched chain. END-3 helps activate END-1, and the two have overlapping specification functions. Their output includes ELT-7 and ELT-2, which stabilize and execute an intestinal differentiation programme through feedback and activation of differentiated targets. Perturbing MED-binding sites in the end genes produces graded, variable gut defects, demonstrating why a binary gut/no-gut score can conceal network robustness.^[ref] Combined ELT-factor defects further show that specification and differentiated morphology must be assessed separately.^[ref]

First establish what the mutant actually loses. I would backcross the temperature-sensitive allele, measure penetrance at permissive and restrictive temperatures, and compare mutant embryos with wild-type siblings exposed to the same temperatures. Differential-interference-contrast imaging combined with a nuclear lineage label would follow EMS, its division orientation, E-cell birth, subsequent divisions, internalization and survival. I would score cell death and cell-cycle delay, not simply missing gut granules. Independent readouts would include endogenous transcripts encoding END-1 and END-3, ELT-2/ELT-7 expression, an intestinal structural marker and later intestinal morphology or lumen formation. Endogenous transcript detection controls for a transgene being selectively silenced or delayed. Stage matching by division history prevents temperature-dependent developmental rate from masquerading as altered expression timing. Loss of E-specific expression with ectopic MS-like descendants would support a fate transformation; normal early E identity with later degeneration or failed lumen formation would support a maintenance or differentiation defect.

Reciprocal temperature-shift experiments locate a functional interval. embryos maintained permissively would be shifted up at successive lineage-defined stages; a second series would start restrictively and be shifted down. Short restrictive pulses would refine any interval around the EMS division, early E divisions or later differentiation. An early upshift that causes gutlessness, a later upshift that does not, and rescue by a sufficiently early downshift would identify a temperature-sensitive period. If late shifts still damage an already marked intestine, an additional maintenance role is likely. I would measure recovery of a functional tagged GUT-1 protein, if available, because inactivation, refolding and protein perdurance broaden the observed interval. These experiments estimate when function is required, not necessarily when the gene is first transcribed. Wild-type pulse controls, matched handling and multiple clutches distinguish conditional loss of function from heat damage. Reciprocal crosses and separate shifts of mothers during oogenesis versus embryos would test maternal contribution and distinguish maternal-effect from zygotic requirements.

The site of expression and the site of requirement need separate tests. A rescuing endogenous knock-in could reveal whether GUT-1 is present in P2, EMS/E or surrounding tissue, but expression is not proof of cell autonomy. I would test rescue restricted to the signalling lineage versus EMS/E using promoters active before the inferred requirement; each construct must demonstrably produce functional protein at the relevant time. Late intestinal promoters cannot exclude an early E-lineage requirement if they fail to rescue. Marked genetic mosaics provide an independent test, provided loss of the rescuing element occurs before the sensitive interval and residual maternal protein is considered. With a suitable conditional system, local inactivation in P2 versus EMS would complement these experiments. Systemic RNA interference alone would not establish which cell requires the gene.

The most direct induction experiment would isolate EMS and recombine it with P2 in four genotype combinations. With otherwise viable blastomeres, mutant P2 failing to induce wild-type EMS suggests a signalling defect; wild-type P2 failing to induce mutant EMS suggests a responding-cell or downstream defect. Wild-type P2 plus wild-type EMS is the positive control; isolated EMS and EMS recombined with an irrelevant blastomere are negative controls. Contacts must be established at equivalent stages and orientations, with cleavage and survival recorded. The classic observation that P2, but not the other early neighbours, restores gut differentiation to isolated EMS establishes the logic of this assay.^[ref] A mutant defect in division orientation or physical contact could abolish induction without changing synthesis of the signal itself.

Finally, I would combine temporal readouts with epistasis and controlled genetic bypass experiments. Compare POP-1/SYS-1 asymmetry, MED activity, END-1/END-3 activation and ELT output in gut-1 embryos. Then express an END factor transiently in the correct early lineage, or an ELT factor at an appropriate later stage, while keeping endogenous controls and matched expression levels. Rescue by END-1 of missing end-gene activation would place the defective function upstream of, or parallel to an input bypassed by, END-1. Normal end-gene activation with failure of ELT induction would point later; persistence of early regulators with loss only of structural targets would point later still. Lack of rescue is interpretable only if the transgene is functional and the cells retain developmental competence. Because POP-1 can both repress and activate, simple POP-1 removal can produce misleading suppression or enhancement; its molecular output must be measured. Double-mutant enhancement could reveal parallel inputs rather than a linear order. Mapping, sequence identification, independent alleles and rescue by a wild-type genomic copy would establish the responsible locus. Direct promoter occupancy, a rapid transcriptional response and endogenous binding-site mutation would be needed before claiming direct regulation of a known target. The outcome should be a tested temporal and cellular requirement with constrained network relationships, not a position assigned from a single rescue.